How Bristol-Myers Squibb Trounced Wall Street's Q4 Estimates

How Bristol-Myers Squibb Trounced Wall Street's Q4 Estimates

Source: 
Motley Fool
snippet: 

All you have to do to gauge how good Bristol-Myers Squibb's (NYSE: BMY) fourth-quarter numbers were is look at the drugmaker's share price. The company announced its 2019 fourth-quarter and full-year results before the market opened on Thursday. Shares jumped close to 3% in early trading.